2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
A new survey by McKesson Health Solutions and released at America's Health Insurance Plan's Institute 2014 conference examined the state of value-based reimbursement, and found that of the existing value-based models, payers and hospitals/health systems predict pay-for-performance (P4P) will experience the most growth
A new survey by McKesson Health Solutions and released at America’s Health Insurance Plan’s Institute 2014 conference examined the state of value-based reimbursement, and found that of the existing value-based models, payers and hospitals/health systems predict pay-for-performance (P4P) will experience the most growth — increasing from 10% today to 18% in 5 years for payers and from 9% to 21% for hospitals/health systems.
The survey, “The State of Value-Based Reimbursement and the Transition from Volume to Value in 2014,” reports that most payers and providers expect value-based reimbursement to overtake fee-for-service (FFS) by the year 2020. However, they face daunting complexity in integrating complex reimbursement models. Providers and clinicians report they have an urgent need for next-generation healthcare IT to successfully transition to value-based models.
Overall, the survey identified these major trends:
McKesson surveyed high-level executives from 114 payers and 350 hospitals/health systems about the VBR models they are using; where they are in the transition to value-based models; and how the financial impact of the models on their businesses.
Related Content: